Ask Warren

CMG Pharmaceutical

058820 · KOSDAQ · ₩058820 · CMG제약

₩4,370▼ ₩150 (3.32%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩28B₩26B₩32B₩30B₩23B₩21B₩27B₩25B
Cost of sales₩13B₩12B₩14B₩12B₩9.6B₩8.7B₩13B₩14B
Gross profit₩15B₩14B₩18B₩18B₩13B₩12B₩14B₩11B
Operating income−₩3B−₩2.9B₩1B₩1.2B−₩4.6B−₩1.3B₩460M₩134M
Net income₩2B₩113M−₩16B₩17B−₩9.3B−₩1.6B₩5.4B−₩8.7B
Net income to shareholders₩2.1B₩113M−₩16B₩17B−₩9.3B−₩1.6B₩5.4B−₩8.7B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩320B₩319B₩306B₩308B₩308B₩306B₩303B₩305B
Current assets₩83B₩94B₩95B₩107B₩129B₩137B₩135B₩133B
Cash and equivalents₩12B₩9.2B₩6.1B₩3.5B₩6.3B₩2.7B₩2.6B₩3.5B
Total liabilities₩116B₩118B₩104B₩103B₩110B₩118B₩114B₩109B
Current liabilities₩71B₩75B₩104B₩100B₩95B₩102B₩75B₩83B
Borrowings₩68B₩88B₩72B₩70B₩71B₩56B₩80B₩76B
Total equity₩204B₩202B₩202B₩204B₩197B₩188B₩190B₩196B
Shareholders' equity₩204B₩202B₩202B₩204B₩197B₩188B₩190B₩196B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩726M−₩1.9B−₩4.1B−₩4B−₩384M−₩2.5B−₩3.8B₩3.2B
Capital spending₩9.4B₩13B₩8.6B₩8.1B₩11B₩2.3B₩3.7B₩4.9B
Free cash flow−₩10B−₩15B−₩13B−₩12B−₩11B−₩4.8B−₩7.5B−₩1.7B
Dividends paid—₩0₩0——₩0₩0₩0

Consolidated where available. Amounts in won.

Also known as: CMG Pharmaceutical / CMG제약 / 058820 / KRX:058820

Source: KRX statistical information